Interv Akut Kardiol. 2018;17(2):100-106 | DOI: 10.36290/kar.2018.045
Within the last fifteen years, endovascular therapy has become the treatment of choice for complicated distal aortic dissection,distal arch repair and blunt thoracic aortic injuries. The identification and early detection of patients who are at risk of deathor disease progression is a major part of aortic dissection management. Even those with clinically silent uncomplicated distaldissection, long- term data suggest survival benefit from stent-induced remodelling of dissected aorta. Recent developmentsin the knowledge of factors predicting aortic expansion enable lesion-specific management tailored to the patient and aorticlesion. Further work is required to identity the subgroup of patients who might be most likely to benefit from early endografting.
Published: May 1, 2018 Show citation